SCHEMBL30786255

SCHEMBL30786255

C=Cc1nn(C2CCCCO2)c2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K5 Q99683 1/20 0.36
PER2 O15055 2/20 0.34
CRY1 Q16526 2/20 0.34
CRY2 Q49AN0 2/20 0.34
RET P07949 1/20 0.33
DGAT2 Q96PD7 1/20 0.33
CYP4F2 P78329 2/20 0.33
CYP4A11 Q02928 2/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
PARP1 P09874 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TSHR P16473 1/20 0.33
IDO1 P14902 1/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
ATR Q13535 2/20 0.32
PDE4A P27815 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16101090 0.88 MAP3K5 (0.36) MAP3K5PER2CRY1CRY2RET
SCHEMBL30775616 0.88 MAP3K5 (0.36) MAP3K5PER2CRY1CRY2RET
SCHEMBL31206321 0.84 CYP4F2 (0.38) RETCYP4F2CYP4A11RXRARXRB
SCHEMBL14493344 0.83 CYP4F2 (0.37) RETCYP4F2CYP4A11RXRARXRB
SCHEMBL26924742 0.83 MAPT (0.36) RETCYP4F2CYP4A11RXRARXRB
SCHEMBL30673111 0.83 MAPT (0.36) RETCYP4F2CYP4A11RXRARXRB
SCHEMBL29705188 0.81 FGFR1 (0.38) MAP3K5RETCYP4F2CYP4A11PARP1
SCHEMBL18198891 0.81 FGFR1 (0.38) MAP3K5RETCYP4F2CYP4A11PARP1
SCHEMBL31190737 0.80 DGAT2 (0.36) MAP3K5RETDGAT2CYP4F2CYP4A11
SCHEMBL31411379 0.80 ESR1 (0.40) MAP3K5RETCYP4F2CYP4A11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024032584-A1 PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF 苏州必扬医药科技有限公司 2024-02-15 WO disclosed